California Inc.: Want to be in the drone biz? Pass this test

Welcome to California Inc., the weekly newsletter of the L.A. Times Business section. Pharmaceutical company Mylan is still in the news after hiking the price of life-saving EpiPens by more than 400%. But keep this in mind: Of roughly 250 million raised for and against 17 ballot measures coming before California voters in November, more than a quarter of that amount -- about 70 million -- has been contributed by deep-pocketed drug companies to defeat the Drug Price Relief Act, which would limit drug prices charged to state healthcare programs. Spending on the measure could set a state record over coming weeks. No buzz kill: New federal rules for small commercial drones go into effect Monday.